首页> 美国卫生研究院文献>American Journal of Translational Research >Percutaneous re-circulating isolated limb perfusion of gentamicin in a large animal model: targeted delivery of gentamicin to limb
【2h】

Percutaneous re-circulating isolated limb perfusion of gentamicin in a large animal model: targeted delivery of gentamicin to limb

机译:大型动物模型中庆大霉素的经皮循环隔离离体肢体灌注:将庆大霉素靶向递送至肢体

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Objective: We have developed a percutaneous recirculation system (V-Vascular, V-V) to enable delivery of high levels of antibiotic to the limb in an isolated and targeted manner for the treatment of limb infection. Background: Chronic and acute limb infections are relatively commonplace in a variety of wound types. Infection can become refractory to existing treatment strategies and can cause complications associated with wound healing, lead to amputation and even death. Methods: Gentamicin was delivered to the ovine hind limb (4 mg/kg) using the V-V system, a ‘closed’ recirculatory catheter system that draws blood from the venous system and returns it to the artery via an oxygenator, or via intra-venous (IV) infusion. Samples of muscle, bone and synovial fluid of the limb were collected at 30 and 60 min post administration of gentamicin. Results: There was a significantly greater concentration of gentamicin observed in the bone and skeletal muscle of limbs receiving the antibiotic via V-V at 30 min post administration compared to IV delivery, (bone V-V 0.05 ± 0.04, I.V 0.004 ± 0.001 mg/L p<0.05; muscle V-V 0.005 ± 0.001, I.V 0.002 ± 0.0005 mg/L p<0.05) and bone and synovial fluid at 60 min post administration (bone V-V 0.06 ± 0.02, I.V 0.005 ± 0.001 mg/L p<0.05; synovial fluid V-V 34.58 ± 14.9, I.V 3.03 ± 0.59 mg/L p<0.05). Conclusions: These results suggest that the use of percutaneous recirculation is a safe and effective method for delivering a greater concentration of antibiotic to the limb without systemic implications.
机译:目的:我们已经开发了一种经皮循环系统(V-Vascular,V-V),能够以隔离和针对性的方式向肢体输送高水平的抗生素,以治疗肢体感染。背景:慢性和急性肢体感染在各种伤口类型中相对司空见惯。感染可能使现有治疗策略变得难治,并可能导致与伤口愈合相关的并发症,导致截肢甚至死亡。方法:使用VV系统将庆大霉素递送至绵羊后肢(4 mg / kg),该系统为“封闭”循环导管系统,可从静脉系统中抽血,并通过充氧器或静脉内将其返回至动脉(四)输液。给予庆大霉素后第30和60分钟收集肢体的肌肉,骨骼和滑液样品。结果:与静脉内给药相比,给药后30分钟通过VV接受抗生素治疗的四肢的骨骼和骨骼肌中庆大霉素的浓度明显更高(骨骼VV 0.05±0.04,IV 0.004±0.001 mg / L p < 0.05;肌肉VV 0.005±0.001,IV 0.002±0.0005 mg / L p <0.05)给药后60分钟时的骨和滑液(骨VV 0.06±0.02,IV 0.005±0.001 mg / L p <0.05;滑液VV 34.58±14.9,IV 3.03±0.59mg / L,p <0.05)。结论:这些结果表明,经皮再循环是一种安全有效的方法,可向肢体输送更高浓度的抗生素而无全身性影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号